TRDA - Entrada Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TRDA is currently covered by 2 analysts with an average price target of $23. This is a potential upside of $9.7 (234.3%) from yesterday's end of day stock price of $6.88.

Entrada Therapeutics's activity chart (see below) currently has 36 price targets and 30 ratings on display. The stock rating distribution of TRDA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28.33% with an average time for these price targets to be met of 89.75 days.

Highest price target for TRDA is $23, Lowest price target is $23, average price target is $23.

Most recent stock forecast was given by from HC WAINWRIGHT on 08-May-2026. First documented stock forecast 24-Nov-2021.

Best performing analysts who are covering TRDA - Entrada Therapeutics:

Raghuram Selvaraju Boobalan Pachaiyappan Chris Shibutani Francois Brisebois Hartaj Singh

Currently out of the existing stock ratings of TRDA, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Apr-2023

$20

4 months 8 days ago
(08-May-2026)

5/15 (33.33%)

$8.96 (81.16%)

175

Buy Since 26-Aug-2024

$23

$15.26 (197.16%)

$30

5 months 10 days ago
(06-Apr-2026)

0/4 (0%)

$9.12 (65.71%)

Buy Since 03-Apr-2023

$17

$9.26 (119.64%)

$20

1 years 1 months 9 days ago
(07-Aug-2025)

3/10 (30%)

$11.7 (220.75%)

177

Buy Since 05-Jan-2024

$30

$18.07 (151.47%)

$28

1 years 5 months 23 days ago
(24-Mar-2025)

0/3 (0%)

$19.2 (177.78%)

Hold Since 24-Nov-2021

$18

$4.5 (33.33%)

$13

3 years 10 months 8 days ago
(08-Nov-2022)

4/4 (100%)

$-1.2 (-6.25%)

14

Show more analysts

Please expand the browser size to see the chart

What is TRDA (Entrada Therapeutics) average time for price targets to be met?

On average it took 90 days for the stock forecasts to be reached, with an average price target met ratio of 28.33%.

Which analyst most recently updated their price target on TRDA (Entrada Therapeutics)?

Which analyst has the most public recommendations on TRDA (Entrada Therapeutics)?

has 0 price targets and 0 ratings on TRDA

Which analyst is the currently most bullish on TRDA (Entrada Therapeutics)?

Hartaj Singh with the highest potential upside of $18.07

Which analyst is the currently most reserved on TRDA (Entrada Therapeutics)?

Raghuram Selvaraju with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?